Eyeglasses target myopia prevention with artificial light

Article

The amount of light effused by these round-shaped eyeglass frames are designed to match the exact wavelength of sunlight a user would be exposed to outside.


With approximately 50% of the world’s population expected to develop myopia by 2050,1 clinical and technological advancements are being made to combat this growing eye health concern.

Betterlab has created eyeglasses that target myopia prevention through the use of artificial light. Photo credit: Betterlab

Betterlab has created eyeglasses that target myopia prevention through the use of artificial light. Photo credit: Betterlab

One latest advancement is a pair of eyeglasses that aims to solve myopia through the use of artificial light.

This wearable technology was developed by Betterlab—an innovation partner and firm—and designed by former NASA scientist Todd Bracher, the company’s lead strategist.

The company and its myopia-preventing glasses were recent finalists in the North America category of the 2022 World Changing Ideas Awards hosted by Fast Company.

The minimal round eyewear-designed glasses work by using a photoluminescent substance—“light rings”—implanted in the edge of the eyewear frame to transmit 480 nm of spectrum light to the eye.

he minimal round eyewear-designed glasses work by using a photoluminescent substance—“light rings”—implanted in the edge of the eyewear frame to transmit 480 nm of spectrum light to the eye.

The minimal round eyewear-designed glasses work by using a photoluminescent substance—“light rings”—implanted in the edge of the eyewear frame to transmit 480 nm of spectrum light to the eye. Photo credit: Betterlab


This then activates retinal dopamine release, creating a positive effect on reducing axial elongation of the eye, a malformation which leads to myopia.

The glasses themselves are a single frame with no actual lenses. However, after just a minute of sunlight or strong lamplight, the glasses glow for a full 25 minutes.

The amount of light that the eyeglasses provide the user with matches the exact wavelength of sunlight, according to the company.

The thought, according to the glasses’ designers, is that experiencing the wavelength twice a day will be enough to prevent myopia development.

The photoluminescent pigment featured in the frame is sourced from a single supplier and mixed into the resin of the glasses so as not to scratch away.

“If you’re in a dark room, you’ll see a glowing effect that’s really cool,” Bracher said in a recent article by Fast Company. “We wanted to destigmatize [myopia treatment], where there are a lot of Coke bottle glasses. We thought these would be more fun.”

This design is currently patent-pending and has not yet been validated by a third-party research.


Reference

1. Holden BA, Fricke TR, Wilson DA, Wong TY, Naduvilath TJ, Resnikoff S. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016 May;123(5):1036-42. doi: 10.1016/j.ophtha.2016.01.006

Recent Videos
Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.
Brianna Rhue, OD, FAAO, FSLS, reviewed key takeaways from The Future of Myopia Management: Perspectives from Leading Experts talk from SECO 2025.
Dr. Julie Rodman previews her SECO presentations
Three EnVision Summit faculty members weigh in on the importance of comanagement in glaucoma management, where artificial intelligence will lead eye care, and what hopes are on the horizon for corneal ectasia treatments.
Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, weighs in on what's on the horizon for pediatric myopia management, and provides some tips for diving into scleral lens fitting.
Ashley Mills, The Vision Council CEO, outlines new additions to the show that are unveiling what is to come in terms of fashion, technology, and patient care.
Walline, OD, PhD, FAAO, outlines how to predict myopia progression and delay its onset in an exclusive interview with Optometry Times.
Jeffrey Walline, OD, PhD, FAAO, overviews a presentation he gave on the Bifocal Lenses in Nearsighted Kids 2 (BLINK2) cohort study at the Collaborative Community on Ophthalmic Innovation (CCOI).
Walline, OD, PhD, FAAO, states that the best way to learn the benefits of artificial intelligence for your practice is to stay on top of continuing education attendance.
© 2025 MJH Life Sciences

All rights reserved.